Related Experiment Video

Updated: Apr 8, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

41.7K

High-Flow Nasal Cannula and Aerosolized β Agonists for Rescue Therapy in Children With Bronchiolitis: A Case Series

Sherwin E Morgan1, Steve Mosakowski2, Patti Solano2

  • 1Department of Respiratory Care sherwin.morgan@uchospitals.edu.

Respiratory Care
|June 25, 2015
PubMed

Insights

High-flow nasal cannula oxygen (HFNC) combined with nebulized bronchodilators improved infant respiratory distress. Infants tolerated inhaled therapy better with HFNC compared to facemasks.

Area of Science:

  • Pediatrics
  • Pulmonology
  • Critical Care Medicine

Background:

  • Asthma and bronchiolitis are common obstructive pulmonary diseases in infants.
  • These conditions involve bronchoconstriction, airway inflammation, and mucus production, leading to airflow obstruction.
  • Acute exacerbations often require respiratory support and medication delivery.

Observation:

  • This study examined the use of high-flow nasal cannula oxygen (HFNC) combined with an Aerogen nebulizer for aerosolized beta-agonist therapy in 5 infants with acute bronchiolitis and respiratory distress.
  • The delivery method's impact on physiological parameters and patient tolerance was assessed.

Findings:

  • High-flow nasal cannula oxygen (HFNC) resulted in a greater heart rate increase compared to facemask delivery in infants receiving inhaled therapy.
  • Patients demonstrated better tolerance of inhaled bronchodilator therapy when administered via HFNC compared to a facemask.

Implications:

  • HFNC may be a more effective and tolerable method for delivering aerosolized medications to infants with respiratory distress.
  • This approach could potentially improve treatment outcomes for pediatric obstructive pulmonary diseases.
  • Further research is warranted to confirm these findings in larger cohorts.

Keywords:
HFNCasthmabronchiolitishigh-flow nasal cannulaβ agonists

More Related Videos

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.7K
A Novel Rescue Technique for Difficult Intubation and Difficult Ventilation04:46

A Novel Rescue Technique for Difficult Intubation and Difficult Ventilation

Published on: January 17, 2011

22.2K

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
1.1K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
2.1K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
669
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K